Eagle Pharmaceuticals Announces Commercial Availability of Docetaxel Injection, Non-Alcohol Formula - Teikoku Pharma

Lidoderm®
Versatis®
Non-Alcohol Docetaxel Injection

TPU-006
TPU-010
TK-254R

Hydrohesive
Matrix

Parent Company
Management
Scientific Advisory Board
Partnerships
Affiliates
Careers
News & Press

Lidoderm®
Versatis®
Non-Alcohol Docetaxel Injection

TPU-006
TPU-010
TK-254R

Hydrohesive
Matrix

Parent Company
Management
Scientific Advisory Board
Partnerships
Affiliates
Careers
News & Press

Eagle Pharmaceuticals Announces Commercial Availability of Docetaxel Injection, Non-Alcohol Formula

Company
Parent Company
Management
Scientific Advisory Board
Partnerships
Affiliates
Careers
News & Press

February 02, 2016 Mia Maslanka

Eagle Pharmaceuticals Announces Commercial Availability of Docetaxel Injection, Non-Alcohol Formula

Lidoderm®
Versatis®
Non-Alcohol Docetaxel Injection

TPU-006
TPU-010
TK-254R

Hydrohesive
Matrix

Parent Company
Management
Scientific Advisory Board
Partnerships
Affiliates
Careers
News & Press

TEIKOKU PHARMA USA

1718 Ringwood Ave San Jose, CA 95131
Main: (408) 501-1800
Fax: (408) 501-1900

SUBSCRIBE FOR LATEST UPDATES

"*" indicates required fields

EMAIL*

Untitled

I agree to be contacted per Teikoku Pharma Privacy Policy

©2023 Teikoku Pharma, All Rights Reserved

CONNECT WITH US ON LINKEDIN